Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
257.12
+2.55 (1.00%)
Bozor ochiq: Aug 12, 2026, 12:28 PM EDT
254.57
0.00 (0.00%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
Ascendis Pharma A/S Yevropa, Qo'shma Shtatlar va xalqaro miqyosda tibbiy ehtiyojlarni qondirish uchun TransCon asosidagi terapiyalarni ishlab chiqishga qaratilgan biofarmatsevtika kompaniyasi sifatida faoliyat yuritadi. Kompaniya o'sish gormoni etishmovchiligi bo'lgan bolalarni davolash uchun SKYTROFA; va surunkali gipoparatiroidizm bilan og'rigan kattalarni davolash uchun kuniga bir marta ter underiga yuboriladigan YORVIPATHni taklif etadi. Shuningdek, u klinik rivojlanish bosqichidagi uchta mustaqil endokrinologiya noyob kasalliklari mahsulot nomzodlarining portfelini ishlab chiqmoqda, shuningdek, onkologiya terapevtik nomzodlarini ilgari surishga qaratilgan. Kompaniya 2006 yilda tashkil etilgan va Daniyaning Hellerup shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Kennett Sprogoe Ph.D. | Executive VP and Head of Research & Product Development |
| Mr. Chad Fugure | Vice President of Investor Relations |
| Mr. Flemming Steen Jensen | Executive Vice President of Product Supply & Quality |
| Mr. Joseph Kelly | Head of U.S. Commercial of Endocrinology |
| Mr. Mads Bodenhoff | Senior VP, Head of Finance & Principal Accounting Officer |
| Mr. Michael Wolff Jensen L.L.M. | Executive VP, Chief Legal Officer & Member of the Executive Board |
| Ms. Sherrie Lynn Glass | Chief Business Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-06 | 6-K | d169607d6k.htm |
| 2026-07-15 | 6-K | d109910d6k.htm |
| 2026-06-30 | 6-K | d93159d6k.htm |
| 2026-06-29 | 6-K | d22299d6k.htm |
| 2026-06-17 | 6-K | d78361d6k.htm |
| 2026-06-15 | 6-K | d48156d6k.htm |
| 2026-06-12 | 6-K | d136465d6k.htm |
| 2026-06-10 | 6-K | d85296d6k.htm |
| 2026-05-22 | SD | d227592dsd.htm |
| 2026-05-13 | 6-K | d865415d6k.htm |